Roy has focused on angel and early stage investments in leading edge enterprises in the technology, biotechnology, pharma and life sciences sectors in Israel. Currently, Roy is an advisor to StageOne Ventures and is a co-founder of SEPL Pharma. Roy hold a bachelor’s degree in economics and Statistics as well as MBA from the Hebrew university of Jerusalem and B.Sc. in Biotechnology from Tel Aviv University. Roy serves as a Board Member in the International Board of the Weizmann Institute of Science. The Weizmann Institute of Science is one of the world’s leading multidisciplinary basic research institutions in the natural and exact sciences. Roy serves as the founder and Managing Partner of ITI – Venture Capital Partners, an investment firm he co-founded with the support of Investec Bank to invest with entrepreneurs in extraordinary Israeli technology companies. ITI’s strategic focus is on building intellectual and corporate competencies in Israel and maintaining the operating nucleus in the country throughout the phases of maturation.